The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Open accessThe DOI matches its Crossref record; 251 of the 253 references it cites were found in a registry or an index.
Abstract
For years, it has been reported that Alzheimer’s disease (AD) is the most common cause of dementia. Various external and internal factors may contribute to the early onset of AD. This review highlights a contribution of the disturbances in the microbiota–gut–brain (MGB) axis to the development of AD. Alteration in the gut microbiota composition is determined by increase in the permeability of the gut barrier and immune cell activation, leading to impairment in the blood–brain barrier function that promotes neuroinflammation, neuronal loss, neural injury, and ultimately AD. Numerous studies have shown that the gut microbiota plays a crucial role in brain function and changes in the behavior of individuals and the formation of bacterial amyloids. Lipopolysaccharides and bacterial amyloids synthesized by the gut microbiota can trigger the immune cells residing in the brain and can activate the immune response leading to neuroinflammation. Growing experimental and clinical data indicate the prominent role of gut dysbiosis and microbiota–host interactions in AD. Modulation of the gut microbiota with antibiotics or probiotic supplementation may create new preventive and therapeutic options in AD. Accumulating evidences affirm that research on MGB involvement in AD is necessary for new treatment targets and therapies for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This process is accompanied by imbalanced neurotransmission,218 which ultimately leads to neuronal degeneration and damage.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [218]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 1×
“The immune system modulates the gut microbiota framework and issuance [171], while in return, the microbial symbionts control immune system maturation and function [172,173].”
BackgroundAFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,149 · cited 1×
“Probiotics are defined as living microbial feed supplements which show a beneficial effect on the host, resulting in improved intestinal microbial balance [230].”
BackgroundHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · cited 2×
“SCFA claimed to reestablish microglial density and normalized CSF1R surface expression [203].”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 1×
“The individuals in the nursing home had less microbiota attributed to a limited diet [59].”
BackgroundGut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001 · cited 9×
“Claims on the potential involvement of the gut microbiota in brain function are made, in part, due to the well-described pathways of communication between the brain and the GIT which has been intensively studied in the area of food intake, satiety, and regulation of the digestive tract [109].”
BackgroundInfluentialDietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
Gut microbiota functions: metabolism of nutrients and other food components
Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1445-8 · Cited by 2,878 · cited 1×
“These findings suggest that the microbiota performs numerous vital functions in our body, including releasing biochemical by-products such as SCFA and gases [88].”
BackgroundDel Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4581 · Cited by 2,601
Cited by
Items 101–200 of 347
Microglia isolation from aging mice for cell culture: A beginner’s guide
Vijaya, A. K., Iešmantaitė, M., Mela, V., Baltriukienė, D., & Burokas, A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1082180 · Cited by 26
Self-citationPolyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease
Brooks, W. H. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231184 · Cited by 25
Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease
Peddinti, V., Avaghade, M. M., Suthar, S. U., Rout, B., Gomte, S. S., Agnihotri, T. G., & Jain, A. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.02.019 · Cited by 25
Vijaya, A. K., Kuras, S., Šimoliūnas, E., Mingaila, J., Makovskytė, K., Buišas, R., Daliri, E. B., Meškys, R., Baltriukienė, D., & Burokas, A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.022 · Cited by 23
“In the CNS, cellular ageing and dysfunction is exacerbated by chronic neuroinflammation (Megur et al., 2020; Mou et al., 2022; Müller et al., 2019).”
BackgroundSelf-citationMunteanu, C., Iordan, D. A., Hoteteu, M., Popescu, C., POSTOIU, R. L., Onu, I., & Onose, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015481 · Cited by 24
Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases
Nie, T., Li, Y., Tang, F., Duan, Y., Nepovimová, E., Kuča, K., Wu, Q., & Wei, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241101093436 · Cited by 24
Zhou, T., Liu, Y., Wang, Q., Dou, Q., Li, X., Pan, Y., Meng, L., & Xue, T. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104706 · Cited by 22
Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer’s Disease Treatment
Song, Y., Zhu, X., Zhang, X.-M., & Xiong, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179703 · Cited by 23
“[19], the “cholinergic hypothesis” [20], neuroinflammation [21,22], metabolic disorders”
BackgroundMaftoon, H., Siadat, S. D., Tarashi, S., Soroush, E., Asefi, M. B., Foroushani, A. R., & Dallal, M. M. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149280 · Cited by 22
Megur, A., Ambrutaitytė, K., Šimoliūnas, E., Lastauskienė, E., & Burokas, A. (2025) · LWT · doi:10.1016/j.lwt.2025.117547 · Cited by 21
Self-citationButyrate: a key mediator of gut-brain communication in Alzheimer’s disease
Kachoueiyan, F., Kalkhoran, N. Y., Kalkhoran, A. Y., Kyada, A., Rekha, M. M., Chaudhary, K., Barwal, A., Sead, F. F., & Joshi, K. K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01617-7 · Cited by 23
“Scientists have become interested in the rela - tionship between AD and gut microbiota throughout the last decade (Megur et al. 2020 ).”
Microbial Metabolomes in Alzheimer’s Disease: From Pathogenesis to Therapeutic Potential
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090724 · Cited by 22
Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review
Simão, D. O., Vieira, V. S., Tosatti, J. A. G., & Gomes, K. B. (2023) · Nutrients · doi:10.3390/nu15214661 · Cited by 22
Ma, X., Liu, J., Jiang, L., Gao, Z., Shi, Z., Zhang, N., Wang, Z., Li, S., Zhang, R., & Xu, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140945 · Cited by 23
Gao, J., Zhou, N., Wu, Y., Lu, M., Wang, Q., Xia, C., Zhou, M., & Xu, Y. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03032-9 · Cited by 22
Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota
Wang, J., Zhu, X., Li, Y., Guo, W., & Li, M. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4023006 · Cited by 22
TMAO promotes dementia progression by mediating the PI3K/Akt/mTOR pathway
Hu, X., Zhang, Y., Gu, C., Gu, C., Yao, Y., Yao, Y., Luo, L., & Zhang, Y. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102034 · Cited by 20
Campolim, C. M., Schimenes, B. C., Veras, M. M., Kim, Y., & Prada, P. O. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401800 · Cited by 20
Warren, A., Wynia, Z., Corr, P. G., Devin, M. F., Celikkol, Z., Gordon, L., Farah, M., Karam, M., Villarreal, D., Jackson, S. A., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71023 · Cited by 20
Rocchi, A. J., Ruff, J., Maynard, C. J., Forga, A. J., Señas-Cuesta, R., Greene, E. S., Latorre, J. D., Vuong, C. N., Graham, B. D., Hernández-Velasco, X., et al. (2022) · Animals · doi:10.3390/ani12101273 · Cited by 19
Zeng, H., Zhou, K., Zhuang, Y., Li, A., Luo, B., & Zhang, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1273104 · Cited by 19
“The abnormal accumulation and folding of these proteins contribute to the pathological changes involved in AD, particularly the formation of amyloid-beta (A β ) plaques (Megur et al., 2020).”
BackgroundProtective Role of Electroacupuncture Against Cognitive Impairment in Neurological Diseases
Xin, Y., Zhou, S., Chu, T., Zhou, Y., & Xu, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22999240209102116 · Cited by 19
Pasupalak, J. K., Rajput, P., & Gupta, G. L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177022 · Cited by 19
Jiao, B., Ouyang, Z., Liu, Q., Xu, T., Wan, M., Ma, G., Zhou, L., Guo, J., Wang, J., Tang, B., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331434 · Cited by 19
“Interestingly, we found that interactions existed among the alternate gut microbiota, metabolites, and brain functional connectivity in non-agenarians, suggesting that the microbiota-gut-brain axis is not only involved in neurological diseases 19–21 but also in longevity.”
BackgroundThe Current Potential Pathogenesis of Amyotrophic Lateral Sclerosis
Jiang, S., & Xu, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04269-3 · Cited by 20
“…by intestinal dysbiosis induce the production of a large number of inflammatory factors in the intestine, which enter the CNS and cause neuroinflammatory and immune reactions in brain and spinal cord leading to ALS through destroying the intestinal barrier and the blood–brain barrier [60, 61].”
HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis
Hu, A., Zaongo, S. D., Harypursat, V., Wang, X., Ouyang, J., & Chen, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1428239 · Cited by 19
“Specifically, it has been observed that AD is associated with a decrease in Fusobacteriaceae , Firmicutes , Actinobacteria , and Bifidobacterium , and an increase in Bacteroidetes (Westfall et al., 2017; Megur et al., 2020).”
BackgroundChaudhary, S., Kaur, P., Singh, T. A., Bano, K. S., Vyas, A., Mishra, A. K., Singh, P., & Mehdi, M. M. (2024) · Biogerontology · doi:10.1007/s10522-024-10146-2 · Cited by 21
“These secretions can trigger the immune cells residing in the brain and can activate the immune response leading to neuroinflammation (Jiang et al. 2017; Megur et al. 2020; Shabbir et al. 2021).”
Long, J., Zhang, J., Zeng, X., Wang, M., & Wang, N. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70101 · Cited by 18
The Microbiome–Gut–Brain Axis and Dementia: A Bibliometric Analysis
Sun, H., Feng, Y., Zhang, Q., Li, J., Wang, Y., Su, Z., Cheung, T. C. C., Jackson, T., Sha, S., & Xiang, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416549 · Cited by 21
Oral Health and Cognitive Decline: A Systematic Review of the Periodontitis–Alzheimer’s Connection
Inchingolo, A. M., Inchingolo, A. D., Piras, F., Avantario, P., Ferrante, L., Paduanelli, G., Inchingolo, F., Palermo, A., Dipalma, G., & Corsalini, M. (2025) · Applied Sciences · doi:10.3390/app15126728 · Cited by 18
Kunevičius, A., Vijaya, A. K., Atzeni, A., Mingaila, J., Šimoliūnė, I., Jamontas, R., Kezeviciute, E., Gueimonde, M., Meškys, R., Baltriukienė, D., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1617980 · Cited by 19
“Numerous studies have reported changes in the gut microbiota and reduced microbial diversity in neurodegenerative disorders (Naseribafrouei et al., 2014; De Angelis et al., 2015; Mulak and Bonaz, 2015; Megur et al., 2020).”
Self-citationNeuroinflammation and nutrition in Alzheimer’s disease
Park, H., Ni, M., & Le, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1622571 · Cited by 17
Dagla, I., Gkikas, F., Gikas, E. E., & Tsarbopoulos, A. (2026) · Cells · doi:10.3390/cells15030295 · Cited by 18
Neuroprotection of phytic acid in Parkinson’s and Alzheimer’s disease
Chen, Y., Yuan, W., Xu, Q., & Reddy, M. B. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105856 · Cited by 18
Ren, J., & Xiao, H. (2023) · Life · doi:10.3390/life13122285 · Cited by 22
Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena
Alsaleem, M. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Alrouji, M., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01526-w · Cited by 20
Dutta, M., Weigel, K. M., Patten, K. T., Valenzuela, A. E., Wallis, C., Bein, K. J., Wexler, A. S., Lein, P. J., & Cui, J. Y. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.03.003 · Cited by 17
Lim, L. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1407785 · Cited by 16
The gut microbiome and the brain
Rykalo, N. A., Riehl, L., & Kress, M. (2024) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000717 · Cited by 16
“In the brain, neurotransmission is profoundly disturbed in the absence of a normal gut microbiome [36], and disturbed body-to-brain loops are associated with mental disorders [3,44,48,50,62,75,85,157–159].”
Can probiotics mitigate age-related neuroinflammation leading to improved cognitive outcomes?
Anderson, R. C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1012076 · Cited by 16
Alshammari, F. F., Al-Kuraishy, H. M., Shokr, M. M., Papadakis, M., Alexiou, A. T., & Batiha, G. E. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01940-6 · Cited by 15
Zhang, Y., Liu, J., Liu, X., Zhou, Y., Geng, J., Shi, Z., & Ma, L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03595-2 · Cited by 15
“More and more research shows that the disorder of the gut microbiota can affect brain function, especially the function of the nervous system [14–16].”
Review of Phytochemical Potency as a Natural Anti-Helicobacter pylori and Neuroprotective Agent
Tandoro, Y., Chen, B.-K., Ali, A., & Wang, C. (2023) · Molecules · doi:10.3390/molecules28207150 · Cited by 16
Liang, L., Li, S., Huang, Y., Zhou, J., Xiong, D., Li, S., Li, H., Zhu, B., Li, X., Ning, Y., et al. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103567 · Cited by 17
“Recently, a number of studies have indicated that the abundance of gut microbiome was significantly correlated with the brain structure and function in patients with SZ [4, 5] , major depressive disorder [6, 7] , Alzheimer’s disease [8-10] and Parkinson’s disease [11-13] .”
BackgroundZeolite and Neurodegenerative Diseases
Panaiotov, S., Tancheva, L. P., Kalfin, R. E., & Petkova-Kirova, P. S. (2024) · Molecules · doi:10.3390/molecules29112614 · Cited by 16
Kefir as a therapeutic agent in clinical research: a scoping review
Bessa, M. K., Bessa, G. R., & Bonamigo, R. R. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000070 · Cited by 17
Jin, Y., Liang, S., Qiu, J., Jin, J., Zhou, Y., Huang, Y., He, C., Yu, W., Deng, S., Cheng, S., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1323674 · Cited by 15
Topalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 16
León-Arcia, K., Andrade-Guerrero, J., Martínez-Orozco, H., Villegas-Rojas, M. M., Pérez-Segura, I., Ramírez, I. L., Vilches‐Flores, A., Guerra‐Crespo, M., Díaz-Miranda, S. Y., & Soto-Rojas, L. O. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102918 · Cited by 14
Chen, J., Wang, L., Zhou, Y., Zhao, S., Chen, Q., & Zheng, K. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100478 · Cited by 15
“Crosstalk among metabolic organs, the immune sys-tem, and the gut microbiota modulates neuroinflammation, proteo-stasis, and cognitive function [4,5].”
Ning, M., An, L., Dong, L., Zhu, R., Hao, J., Liu, X., & Zhang, Y. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240082 · Cited by 14
Therapeutic potential of fucoidan in central nervous system disorders: A systematic review
Yang, J., Zhao, H., & Qu, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134397 · Cited by 16
Altered cognitive function in obese patients: relationship to gut flora
Deng, M., Tang, F., & Zhu, Z. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05201-y · Cited by 16
Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
Doroszkiewicz, J., Mroczko, P., & Kulczyńska‐Przybik, A. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211202143935 · Cited by 15
Gut Microbiota and Subjective Memory Complaints in Older Women
Wu, F., Davey, S., Clendenen, T. V., Koenig, K. L., Afanasyeva, Y., Zhou, B., Bedi, S., Li, H., Zeleniuch‐Jacquotte, A., & Chen, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220011 · Cited by 15
The roles and mechanisms of gut microbiome and metabolome in patients with cerebral infarction
Qian, W., Wu, M., Qian, T.-T., Xie, C., Gao, Y., & Qian, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1112148 · Cited by 14
Lv, J.-J., Li, X., Wang, J.-B., Yang, X., Yin, M.-Y., & Yang, C.-H. (2024) · Scientific Reports · doi:10.1038/s41598-024-51520-x · Cited by 14
Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer’s Disease
Pavlov, S. A., Prajapati, S. K., Yadav, D., Marcano-Rodriguez, A., Yadav, H., & Jain, S. (2025) · Biomolecules · doi:10.3390/biom16010007 · Cited by 16
Li, L., Yang, Y., Cao, Y., Zhan, J., Wu, Y. X., & Wu, C. (2023) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-23-00012 · Cited by 13
“After treatment with antibiotics, the accumulation of A β was attenuated, [54] implying that the gut microbiota plays a crucial role in neurological diseases.”
Aijaz, M., Ahmad, S., Ahmad, S., Afzal, M., & Kothiyal, P. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04776-7 · Cited by 17
Research trends on the gut microbiota in endocrine metabolism: a thematic and bibliometric analysis
Doğan, D., & Çelik, T. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1371727 · Cited by 13
Ngah, W. Z. W., Ahmad, H. F., Ankasha, S. J., Makpol, S., & Tooyama, I. (2024) · Antioxidants · doi:10.3390/antiox13121504 · Cited by 13
Huang, S., Wang, X., Wang, M., Lin, J., Ren, J., Lu, C., Fu, J., Zhang, Y., Wang, X., Xiao, J., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70417 · Cited by 12
“The intestinal microbiota and barrier are crucial components of the gut–brain axiso [33, 34].”
Liu, W., Guo, J., Dong, Y., Li, J., & Wang, Y. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70037 · Cited by 12
Skawratananond, S., McCrea, G. E., Lie, P. E., Buxton, M. B., Daly, S. P., Vojtkofsky, N. A., Smith, S. C., Zhang, C., Hernandez, M., Hindle, A., et al. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00097.2025 · Cited by 14
Altered Blood Levels of Anti-Gal Antibodies in Alzheimer’s Disease: A New Clue to Pathogenesis?
Angiolillo, A., Gandaglia, A., Arcaro, A., Carpi, A., Gentile, F., Naso, F., & Costanzo, A. D. (2021) · Life · doi:10.3390/life11060538 · Cited by 13
Feng, C., Li, A., Yin, C., Wang, S., Jin, W., Liu, Y., Huo, T., & Jiang, H. (2022) · Nutrients · doi:10.3390/nu14193958 · Cited by 12
“It also produces metabolites which affect brain function [28].”
BackgroundLiu, F., Xu, X., Wang, Z., & Wu, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.966004 · Cited by 12
“…through the microbiota-gut-brain axis, even destroying the activity and function of the central nervous system, and directly resulting in the occurrence of Parkinson’s Disease (PD), Alzheimer’s Disease (AD), and depression (Caputi and Giron, 2018; Liang et al., 2018; Megur et al., 2020).”
BackgroundHe, B., Hu, T., & Wu, H. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102949 · Cited by 11
Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases
Olajide, T. S., & Ijomone, O. M. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70000 · Cited by 11
Christopher, C. J., Morgan, K. H., Tolleson, C., Trudell, R., Fernandez-Romero, R., Rice, L., Abiodun, B. A., Vickery, Z. A., Jones, K. A., Woodall, B., et al. (2025) · Nutrients · doi:10.3390/nu17091597 · Cited by 13
Renesteen, E., Boyajian, J. L., Islam, P., Kassab, A., Abosalha, A. K., Makhlouf, S., Santos, M., Chen, H., Shum-Tim, C., & Prakash, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115351 · Cited by 16
Kachouei, A. A., Singar, S., Wood, A., Flatt, J. D., Rosenkranz, S. K., Rosenkranz, R. R., & Akhavan, N. S. (2025) · Nutrients · doi:10.3390/nu17142328 · Cited by 14
Ren, Y., Liang, J., Xie, J., Hu, W., Lai, M., Li, X., Zhang, J., Zheng, Y., Wu, Q., Zhou, H., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02257-w · Cited by 11
Nayak, A., Bera, S., Purohit, S., & Jain, C. K. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.116019 · Cited by 11
Gut Microbes Regulate Innate Immunity and Epilepsy
Zhang, L., Li, S., Tai, Z., Yu, C., & Xu, Z. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.870197 · Cited by 13
Niu, Y., Zhang, Y., Zha, Q., Shi, J., & Weng, Q. (2024) · Journal of Applied Genetics · doi:10.1007/s13353-024-00827-6 · Cited by 11
“Relevant domestic research results show that there are about 10 million cases of AD in China, and about 25 million people with incipient cognitive impairment, and 44% of patients with incipient cognitive impairment will develop AD after 3 years (Megur et al. 2020).”
Nešković, N., Budrovac, D., Kristek, G., Kovačić, B., & Škiljić, S. (2024) · Journal of Perioperative Practice · doi:10.1177/17504589241229909 · Cited by 11
“Bacterial products can move from the gut to the CNS, especially with ageing, and then trigger microglia cell activation, leading to the progression of neuroinflammation, which results in the loss of neurons and amyloid aggregation (Megur et al 2020, Zhu et al 2020).”
Najdaghi, S., Davani, D. N., Fouladseresht, H., Ebrahimi, N., Sullman, M. J. M., Moradi, M., & Eskandari, N. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01518-w · Cited by 12
Kunevičius, A., Sadauskas, M., Raudytė, J., Meškys, R., & Burokas, A. (2024) · Molecules · doi:10.3390/molecules29050993 · Cited by 10
Self-citationChen, Y., Ho, C., & Zhang, X. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70132 · Cited by 10
The Role of Oral and Gut Microbiota in Bone Health: Insights from Bacterial Extracellular Vesicles
Liang, P., Chen, X., Su, Z., Luo, Y., Wang, T., Jiang, L., Guo, L., & Luo, T. (2025) · Microorganisms · doi:10.3390/microorganisms13102254 · Cited by 10
The Role of Gut Dysbiosis in the Pathophysiology of Tinnitus: A Literature Review
Megantara, I., Wikargana, G. L., Dewi, Y. A., Permana, A. D., & Sylviana, N. (2022) · The International Tinnitus Journal · doi:10.5935/0946-5448.20220005 · Cited by 11
Chen, X., Wei, J., Zhang, Y., Zhang, Y., & Zhang, T. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.122889 · Cited by 11
Ahmadi, S., Hasani, A., Khabbaz, A., Poortahmasebi, V., Hosseini, S., Yasdchi, M., Mehdizadehfar, E., Mousavi, Z. B., Hasani, R., Nabizadeh, E., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10136-4 · Cited by 13
“The most current research showed that disruptions in the microbiota-brain axis might cause neuroinflammation and AD (Megur et al. 2020; Seo and Holtz-man 2024).”
Synaptosomes: A Functional Tool for Studying Neuroinflammation
Trebesova, H., & Grilli, M. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020027 · Cited by 11
The Impact of Gut Microbiota Changes on Methotrexate-Induced Neurotoxicity in Developing Young Rats
Chen, Y.-C. D., Hou, C., Hsu, M., Huang, L., Hsiao, C., & Sheen, J. (2024) · Biomedicines · doi:10.3390/biomedicines12040908 · Cited by 9
Zhong, M., Xu, Q., Huang, M., Zhan, R., Huang, X., Yang, W., Lin, Z., & Xian, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01475-0 · Cited by 10
Wu, W., Meng, T., Han, L., Jin, F., Han, P., & Zhou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1630205 · Cited by 13
Ternák, G., Németh, M., Rozanovic, M., & Bogár, L. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220018 · Cited by 9
Sait, A. M., & Day, P. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168619 · Cited by 9
“Many bacterial species that reside in the gut under normal conditions can produce A β such as Escherichia coli and Bacillus subtilis [63].”
BackgroundGinseng and Polygonum multiflorum formula protects brain function in Alzheimer’s disease
Liu, J., Wei, F., Wang, Y., Liu, J., Xu, B., Ma, S., & Yang, J.-B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1461177 · Cited by 15
Pawlowski, K. D., David, B. T., & Fessler, R. G. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2022.0264 · Cited by 10
Zhang, Y., Wang, J., Li, X., Guo, R., Wang, L., Liu, Y., Yu, Y., & Kong, L. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01180-4 · Cited by 8
Zhang, S., Liu, X., Xu, S., Li, W., Song, J., Tian, Q., & Du, Y. (2025) · Biomolecules · doi:10.3390/biom15111486 · Cited by 9
IMD signaling in the gut and the brain modulates Amyloid-beta-induced deficits in Drosophila
Hsieh, T., & Chiang, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122118 · Cited by 8
Coles, M. E., Graham, B. D., Latorre, J. D., Petrone-García, V. M., Hernández-Velasco, X., Castellanos-Huerta, I., Sun, X., Hargis, B. M., El-Ashram, S. A., Shehata, A. A., et al. (2023) · Food and Nutrition Sciences · doi:10.4236/fns.2023.143016 · Cited by 13
Preclinical Evidence-based Neuroprotective Potential of Silibinin
Singh, N. K., & Bhushan, B. (2023) · Current Drug Research Reviews · doi:10.2174/2589977515666230327154800 · Cited by 9
Yan, L., Li, H., Qian, Y., Liu, Q., Cong, S., Dou, B., Wang, Y., Wang, M., & Yu, T. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1334735 · Cited by 10
“Some evidence has demonstrated that gut microbiota is associated with the pathophysiology of neurodegenerative lesions (Kowalski and Mulak, 2019; Megur et al., 2020; Doifode et al., 2021).”
BackgroundThe association between a pro-inflammatory diet and brain age in middle-aged and older adults
Dunk, M. M., Huang, H., Wang, J., Dove, A. E., Sakakibara, S., Guo, J., Carballo‐Casla, A., Bennett, D. A., & Xu, W. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01318-6 · Cited by 7
Metadata
- Authors
- Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A.
- Affiliations
- Vilnius University (LT)
- Corresponding author
- Burokas, Aurelijus
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-12-24
- Volume
- 13
- Issue
- 1
- Pages
- 37
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7824474
- OpenAlex
- W3115136688
- Cited by
- 323
- References
- 253
- Citations by year
- 2026: 44 · 2025: 75 · 2024: 75 · 2023: 54 · 2022: 57 · 2021: 18
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The European Regional Development Fund under grant agreement with the Research Council of Lithuania (LMTLT) (01.2.2-LMT-K-718-02-0014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, microbiota-gut-brain axis, gut dysbiosis, neuroinflammation, blood-brain barrier, intestinal permeability, lipopolysaccharide, bacterial amyloids, probiotics, antibiotics, dementia
- MeSH terms
- Gastrointestinal Microbiome, Alzheimer Disease, Animals, Anti-Bacterial Agents, Brain, Encephalitis, Humans, Intestines, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.